Renagel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Genzyme Corporation. The primary component is Sevelamer Hydrochloride.
Product ID | 58468-0020_62a626e6-c535-4eb5-af9e-4dd5baac8e6a |
NDC | 58468-0020 |
Product Type | Human Prescription Drug |
Proprietary Name | Renagel |
Generic Name | Renagel |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2008-06-06 |
Marketing End Date | 2020-03-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021179 |
Labeler Name | Genzyme Corporation |
Substance Name | SEVELAMER HYDROCHLORIDE |
Active Ingredient Strength | 400 mg/1 |
Pharm Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2008-06-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021179 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-06-06 |
Marketing End Date | 2020-03-01 |
Ingredient | Strength |
---|---|
SEVELAMER HYDROCHLORIDE | 400 mg/1 |
SPL SET ID: | 5e30120b-f2bf-43a0-86b2-44ae996dc681 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
17856-0021 | Renagel | Renagel |
53808-0777 | Renagel | Renagel |
58468-0020 | Renagel | Renagel |
58468-0021 | Renagel | sevelamer hydrochloride |
67544-656 | Renagel | Renagel |
68151-4295 | RENAGEL | Renagel |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RENAGEL 74590044 1978935 Live/Registered |
GENZYME CORPORATION 1994-10-24 |